Cetuximab-conjugated sodium selenite nanoparticles for doxorubicin targeted delivery against MCF-7 breast cancer cells.
Moni SS, Abdelwahab SI, Mohan S, Riadi Y, Elmobark ME, Areshyi RW, Sofyani HA, Halawi FA, Hakami MQ, Aljahdali IA, Oraibi B, Farasani A, Dawod OY, Alfaifi HA, Alzahrani AH, Jerah AA.
Moni SS, et al.
Nanomedicine (Lond). 2024;19(29):2447-2462. doi: 10.1080/17435889.2024.2403962. Epub 2024 Oct 9.
Nanomedicine (Lond). 2024.
PMID: 39381998
Free PMC article.